The Correlation Between Peroxisome Proliferator-Activated Receptor Alpha and Gamma Polymorphisms and Acute Coronary Syndrome

Objective: This study aims to evaluate the relationship between peroxisome proliferator-activated receptor (PPAR) alpha and gamma gene polymorphisms and acute coronary syndrome (ACS) clinically.Subject and methods: Peripheral blood samples were collected from a total of 200 people, including 100 acu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) CA), 2022-06, Vol.14 (6), p.e26147-e26147
Hauptverfasser: Kemanci, Aykut, Goren, Tarik, Uluturk, Mehmet, Yilmaz, Atakan, Sabirli, Ramazan, Ozen, Mert, Seyit, Murat, Oskay, Alten, Koseler, Aylin, Turkcuer, Ibrahim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e26147
container_issue 6
container_start_page e26147
container_title Curēus (Palo Alto, CA)
container_volume 14
creator Kemanci, Aykut
Goren, Tarik
Uluturk, Mehmet
Yilmaz, Atakan
Sabirli, Ramazan
Ozen, Mert
Seyit, Murat
Oskay, Alten
Koseler, Aylin
Turkcuer, Ibrahim
description Objective: This study aims to evaluate the relationship between peroxisome proliferator-activated receptor (PPAR) alpha and gamma gene polymorphisms and acute coronary syndrome (ACS) clinically.Subject and methods: Peripheral blood samples were collected from a total of 200 people, including 100 acute coronary syndrome patients and 100 controls aged 19 to 93 years, admitted to the Pamukkale University Emergency Medicine Department. The healthy volunteers had no known chronic or acute diseases, no history of drug use, and no recent history of coronary artery disease (CAD). PPAR alpha L162V and PPAR gamma C161T gene polymorphic regions were detected using DNA sequencing analyses. In addition, data collected from the hemogram and biochemical parameters and comorbidities of the patients were statistically analyzed.Results: PPAR gamma C161T polymorphisms were compared between groups. The CT heterozygous rate in the patient group (74%) was higher than in the control group (7%). The T allele was more common in the patient group (0.37) compared to the control group (0.03). When PPAR alpha L162V polymorphism was compared, VV homozygous individuals were %19 in the patient group and none in the control group. The V allele was found to be statistically higher in patients with ACS (p
doi_str_mv 10.7759/cureus.26147
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9301886</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2695285027</sourcerecordid><originalsourceid>FETCH-LOGICAL-c276t-93d3b811c9eb8857a8f4fbe1ae494d9c73ea73d11ae250e7b681868929acf50c3</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi1ERau2N36AJS4cSPFH4o8L0rKCglSpKyhny3EmrKvEDnZSWKk_vu5uhSinGb3z6J0ZvQi9puRCyka_d0uCJV8wQWv5Ap0wKlSlqKpf_tMfo_OcbwkhlEhGJHmFjnmjNFVcnKD7my3gdUwJBjv7GPBHmH8DBLyBFP_4HEfAmxQH30Oyc0zVys3-zs7Q4W_gYCoSXg3T1mIbOnxpx9HiTRx2Y0zT1ucx7_WVW-b9mhhs2uHvu9Cl4nyGjno7ZDh_qqfox-dPN-sv1dX15df16qpyTIq50rzjraLUaWiVaqRVfd23QC3Uuu60kxys5B0tAmsIyFaUt4XSTFvXN8TxU_Th4Dst7QidgzAnO5gp-bGcY6L15vkk-K35Ge-M5oQqJYrB2yeDFH8tkGcz-uxgGGyAuGTDhG6YagiTBX3zH3oblxTKe4-UkEqShhbq3YFyKeacoP97DCXmMVlzSNbsk-UPjAKZLg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2696787051</pqid></control><display><type>article</type><title>The Correlation Between Peroxisome Proliferator-Activated Receptor Alpha and Gamma Polymorphisms and Acute Coronary Syndrome</title><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Kemanci, Aykut ; Goren, Tarik ; Uluturk, Mehmet ; Yilmaz, Atakan ; Sabirli, Ramazan ; Ozen, Mert ; Seyit, Murat ; Oskay, Alten ; Koseler, Aylin ; Turkcuer, Ibrahim</creator><creatorcontrib>Kemanci, Aykut ; Goren, Tarik ; Uluturk, Mehmet ; Yilmaz, Atakan ; Sabirli, Ramazan ; Ozen, Mert ; Seyit, Murat ; Oskay, Alten ; Koseler, Aylin ; Turkcuer, Ibrahim</creatorcontrib><description>Objective: This study aims to evaluate the relationship between peroxisome proliferator-activated receptor (PPAR) alpha and gamma gene polymorphisms and acute coronary syndrome (ACS) clinically.Subject and methods: Peripheral blood samples were collected from a total of 200 people, including 100 acute coronary syndrome patients and 100 controls aged 19 to 93 years, admitted to the Pamukkale University Emergency Medicine Department. The healthy volunteers had no known chronic or acute diseases, no history of drug use, and no recent history of coronary artery disease (CAD). PPAR alpha L162V and PPAR gamma C161T gene polymorphic regions were detected using DNA sequencing analyses. In addition, data collected from the hemogram and biochemical parameters and comorbidities of the patients were statistically analyzed.Results: PPAR gamma C161T polymorphisms were compared between groups. The CT heterozygous rate in the patient group (74%) was higher than in the control group (7%). The T allele was more common in the patient group (0.37) compared to the control group (0.03). When PPAR alpha L162V polymorphism was compared, VV homozygous individuals were %19 in the patient group and none in the control group. The V allele was found to be statistically higher in patients with ACS (p&lt;0.01).Conclusion: The findings revealed that elevated PPAR alpha L162V and PPAR gamma C161T gene polymorphisms were associated with a progressive risk of ACS.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.26147</identifier><identifier>PMID: 35891836</identifier><language>eng</language><publisher>Palo Alto: Cureus Inc</publisher><subject>Acute coronary syndromes ; Angina pectoris ; Apolipoproteins ; Atherosclerosis ; Blood pressure ; Cardiology ; Cardiovascular disease ; Cholesterol ; Coronary vessels ; Cytokines ; Emergency Medicine ; Genetics ; Glucose ; Heart attacks ; High density lipoprotein ; Hypertension ; Kinases ; Lipids ; Lipoproteins ; Metabolism ; Patients ; Polymorphism ; Smooth muscle ; Software ; Thrombosis</subject><ispartof>Curēus (Palo Alto, CA), 2022-06, Vol.14 (6), p.e26147-e26147</ispartof><rights>Copyright © 2022, Kemanci et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2022, Kemanci et al. 2022 Kemanci et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c276t-93d3b811c9eb8857a8f4fbe1ae494d9c73ea73d11ae250e7b681868929acf50c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301886/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301886/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Kemanci, Aykut</creatorcontrib><creatorcontrib>Goren, Tarik</creatorcontrib><creatorcontrib>Uluturk, Mehmet</creatorcontrib><creatorcontrib>Yilmaz, Atakan</creatorcontrib><creatorcontrib>Sabirli, Ramazan</creatorcontrib><creatorcontrib>Ozen, Mert</creatorcontrib><creatorcontrib>Seyit, Murat</creatorcontrib><creatorcontrib>Oskay, Alten</creatorcontrib><creatorcontrib>Koseler, Aylin</creatorcontrib><creatorcontrib>Turkcuer, Ibrahim</creatorcontrib><title>The Correlation Between Peroxisome Proliferator-Activated Receptor Alpha and Gamma Polymorphisms and Acute Coronary Syndrome</title><title>Curēus (Palo Alto, CA)</title><description>Objective: This study aims to evaluate the relationship between peroxisome proliferator-activated receptor (PPAR) alpha and gamma gene polymorphisms and acute coronary syndrome (ACS) clinically.Subject and methods: Peripheral blood samples were collected from a total of 200 people, including 100 acute coronary syndrome patients and 100 controls aged 19 to 93 years, admitted to the Pamukkale University Emergency Medicine Department. The healthy volunteers had no known chronic or acute diseases, no history of drug use, and no recent history of coronary artery disease (CAD). PPAR alpha L162V and PPAR gamma C161T gene polymorphic regions were detected using DNA sequencing analyses. In addition, data collected from the hemogram and biochemical parameters and comorbidities of the patients were statistically analyzed.Results: PPAR gamma C161T polymorphisms were compared between groups. The CT heterozygous rate in the patient group (74%) was higher than in the control group (7%). The T allele was more common in the patient group (0.37) compared to the control group (0.03). When PPAR alpha L162V polymorphism was compared, VV homozygous individuals were %19 in the patient group and none in the control group. The V allele was found to be statistically higher in patients with ACS (p&lt;0.01).Conclusion: The findings revealed that elevated PPAR alpha L162V and PPAR gamma C161T gene polymorphisms were associated with a progressive risk of ACS.</description><subject>Acute coronary syndromes</subject><subject>Angina pectoris</subject><subject>Apolipoproteins</subject><subject>Atherosclerosis</subject><subject>Blood pressure</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Cholesterol</subject><subject>Coronary vessels</subject><subject>Cytokines</subject><subject>Emergency Medicine</subject><subject>Genetics</subject><subject>Glucose</subject><subject>Heart attacks</subject><subject>High density lipoprotein</subject><subject>Hypertension</subject><subject>Kinases</subject><subject>Lipids</subject><subject>Lipoproteins</subject><subject>Metabolism</subject><subject>Patients</subject><subject>Polymorphism</subject><subject>Smooth muscle</subject><subject>Software</subject><subject>Thrombosis</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkU1v1DAQhi1ERau2N36AJS4cSPFH4o8L0rKCglSpKyhny3EmrKvEDnZSWKk_vu5uhSinGb3z6J0ZvQi9puRCyka_d0uCJV8wQWv5Ap0wKlSlqKpf_tMfo_OcbwkhlEhGJHmFjnmjNFVcnKD7my3gdUwJBjv7GPBHmH8DBLyBFP_4HEfAmxQH30Oyc0zVys3-zs7Q4W_gYCoSXg3T1mIbOnxpx9HiTRx2Y0zT1ucx7_WVW-b9mhhs2uHvu9Cl4nyGjno7ZDh_qqfox-dPN-sv1dX15df16qpyTIq50rzjraLUaWiVaqRVfd23QC3Uuu60kxys5B0tAmsIyFaUt4XSTFvXN8TxU_Th4Dst7QidgzAnO5gp-bGcY6L15vkk-K35Ge-M5oQqJYrB2yeDFH8tkGcz-uxgGGyAuGTDhG6YagiTBX3zH3oblxTKe4-UkEqShhbq3YFyKeacoP97DCXmMVlzSNbsk-UPjAKZLg</recordid><startdate>20220621</startdate><enddate>20220621</enddate><creator>Kemanci, Aykut</creator><creator>Goren, Tarik</creator><creator>Uluturk, Mehmet</creator><creator>Yilmaz, Atakan</creator><creator>Sabirli, Ramazan</creator><creator>Ozen, Mert</creator><creator>Seyit, Murat</creator><creator>Oskay, Alten</creator><creator>Koseler, Aylin</creator><creator>Turkcuer, Ibrahim</creator><general>Cureus Inc</general><general>Cureus</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220621</creationdate><title>The Correlation Between Peroxisome Proliferator-Activated Receptor Alpha and Gamma Polymorphisms and Acute Coronary Syndrome</title><author>Kemanci, Aykut ; Goren, Tarik ; Uluturk, Mehmet ; Yilmaz, Atakan ; Sabirli, Ramazan ; Ozen, Mert ; Seyit, Murat ; Oskay, Alten ; Koseler, Aylin ; Turkcuer, Ibrahim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c276t-93d3b811c9eb8857a8f4fbe1ae494d9c73ea73d11ae250e7b681868929acf50c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acute coronary syndromes</topic><topic>Angina pectoris</topic><topic>Apolipoproteins</topic><topic>Atherosclerosis</topic><topic>Blood pressure</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Cholesterol</topic><topic>Coronary vessels</topic><topic>Cytokines</topic><topic>Emergency Medicine</topic><topic>Genetics</topic><topic>Glucose</topic><topic>Heart attacks</topic><topic>High density lipoprotein</topic><topic>Hypertension</topic><topic>Kinases</topic><topic>Lipids</topic><topic>Lipoproteins</topic><topic>Metabolism</topic><topic>Patients</topic><topic>Polymorphism</topic><topic>Smooth muscle</topic><topic>Software</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kemanci, Aykut</creatorcontrib><creatorcontrib>Goren, Tarik</creatorcontrib><creatorcontrib>Uluturk, Mehmet</creatorcontrib><creatorcontrib>Yilmaz, Atakan</creatorcontrib><creatorcontrib>Sabirli, Ramazan</creatorcontrib><creatorcontrib>Ozen, Mert</creatorcontrib><creatorcontrib>Seyit, Murat</creatorcontrib><creatorcontrib>Oskay, Alten</creatorcontrib><creatorcontrib>Koseler, Aylin</creatorcontrib><creatorcontrib>Turkcuer, Ibrahim</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kemanci, Aykut</au><au>Goren, Tarik</au><au>Uluturk, Mehmet</au><au>Yilmaz, Atakan</au><au>Sabirli, Ramazan</au><au>Ozen, Mert</au><au>Seyit, Murat</au><au>Oskay, Alten</au><au>Koseler, Aylin</au><au>Turkcuer, Ibrahim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Correlation Between Peroxisome Proliferator-Activated Receptor Alpha and Gamma Polymorphisms and Acute Coronary Syndrome</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><date>2022-06-21</date><risdate>2022</risdate><volume>14</volume><issue>6</issue><spage>e26147</spage><epage>e26147</epage><pages>e26147-e26147</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Objective: This study aims to evaluate the relationship between peroxisome proliferator-activated receptor (PPAR) alpha and gamma gene polymorphisms and acute coronary syndrome (ACS) clinically.Subject and methods: Peripheral blood samples were collected from a total of 200 people, including 100 acute coronary syndrome patients and 100 controls aged 19 to 93 years, admitted to the Pamukkale University Emergency Medicine Department. The healthy volunteers had no known chronic or acute diseases, no history of drug use, and no recent history of coronary artery disease (CAD). PPAR alpha L162V and PPAR gamma C161T gene polymorphic regions were detected using DNA sequencing analyses. In addition, data collected from the hemogram and biochemical parameters and comorbidities of the patients were statistically analyzed.Results: PPAR gamma C161T polymorphisms were compared between groups. The CT heterozygous rate in the patient group (74%) was higher than in the control group (7%). The T allele was more common in the patient group (0.37) compared to the control group (0.03). When PPAR alpha L162V polymorphism was compared, VV homozygous individuals were %19 in the patient group and none in the control group. The V allele was found to be statistically higher in patients with ACS (p&lt;0.01).Conclusion: The findings revealed that elevated PPAR alpha L162V and PPAR gamma C161T gene polymorphisms were associated with a progressive risk of ACS.</abstract><cop>Palo Alto</cop><pub>Cureus Inc</pub><pmid>35891836</pmid><doi>10.7759/cureus.26147</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2022-06, Vol.14 (6), p.e26147-e26147
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9301886
source PubMed Central; PubMed Central Open Access
subjects Acute coronary syndromes
Angina pectoris
Apolipoproteins
Atherosclerosis
Blood pressure
Cardiology
Cardiovascular disease
Cholesterol
Coronary vessels
Cytokines
Emergency Medicine
Genetics
Glucose
Heart attacks
High density lipoprotein
Hypertension
Kinases
Lipids
Lipoproteins
Metabolism
Patients
Polymorphism
Smooth muscle
Software
Thrombosis
title The Correlation Between Peroxisome Proliferator-Activated Receptor Alpha and Gamma Polymorphisms and Acute Coronary Syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A37%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Correlation%20Between%20Peroxisome%20Proliferator-Activated%20Receptor%20Alpha%20and%20Gamma%20Polymorphisms%20and%20Acute%20Coronary%20Syndrome&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Kemanci,%20Aykut&rft.date=2022-06-21&rft.volume=14&rft.issue=6&rft.spage=e26147&rft.epage=e26147&rft.pages=e26147-e26147&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.26147&rft_dat=%3Cproquest_pubme%3E2695285027%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2696787051&rft_id=info:pmid/35891836&rfr_iscdi=true